CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024	0
Beginning balance at Dec. 31, 2024	$ 0
Ending balance (in shares) at Mar. 31, 2025	0
Ending balance at Mar. 31, 2025	$ 0
Beginning balance (in shares) at Dec. 31, 2024		85,568,000
Beginning balance at Dec. 31, 2024	2,183,243	$ 8,628	$ 1,824,935	$ 526,642	$ (19,095)	$ (157,867)
Shareholders' Equity
Comprehensive income (loss)	58,611			31,464		27,147
Stock-based compensation expense	3,038		3,038
Common stock issued for stock-based employee benefit plans (in shares)		50,000
Common stock issued for stock-based employee benefit plans	289	$ 5	261		23
Dividends on common stock	(15,441)			(15,441)
Increase (decrease) in stockholders' equity during period (in shares)		50,000
Increase (decrease) in stockholders' equity during period	46,497	$ 5	3,299	16,023	23	27,147
Ending balance (in shares) at Mar. 31, 2025		85,618,000
Ending balance at Mar. 31, 2025	$ 2,229,740	$ 8,633	1,828,234	542,665	(19,072)	(130,720)
Beginning balance (in shares) at Dec. 31, 2025	11,250
Beginning balance at Dec. 31, 2025	$ 343,125
Ending balance (in shares) at Mar. 31, 2026	11,250
Ending balance at Mar. 31, 2026	$ 343,125
Beginning balance (in shares) at Dec. 31, 2025	97,927,843	97,928,000
Beginning balance at Dec. 31, 2025	$ 2,712,662	$ 9,873	2,197,549	603,793	(21,358)	(77,195)
Shareholders' Equity
Comprehensive income (loss)	30,503			31,895		(1,392)
Stock-based compensation expense	4,480		4,480
Common stock issued for stock-based employee benefit plans (in shares)		55,000
Common stock issued for stock-based employee benefit plans	840	$ 5	850		(15)
Repurchase of common stock (in shares)		(318,000)
Repurchase of common stock	(10,000)				(10,000)
Dividends on common stock	(18,697)			(18,697)
Dividends on preferred stock	(2,138)			(2,138)
Increase (decrease) in stockholders' equity during period (in shares)		(263,000)
Increase (decrease) in stockholders' equity during period	$ 4,988	$ 5	5,330	11,060	(10,015)	(1,392)
Ending balance (in shares) at Mar. 31, 2026	97,664,704	97,665,000
Ending balance at Mar. 31, 2026	$ 2,717,650	$ 9,878	$ 2,202,879	$ 614,853	$ (31,373)	$ (78,587)